International Stem Cell CORP (ISCO) › Shareholders' EquityInternational Stem Cell CORP (ISCO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2006: $4.70M2007: $212.0K2008: $433.0K2009: -$2.27M2010: $5.39M2011: $3.62M2012: -$1.76M2013: -$4.22M2014: $321.0K2015: $1.59M2016: $3.44M2017: $2.06M2018: $2.54M2019: -$2.89M2020: -$4.33M2021: -$4.59M2022: -$4.52M2023: -$4.19M2024: -$3.93M2025: -$4.06M-$4.06M2006Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$4.06M-3.3%2024-$3.93M+6.1%2023-$4.19M+7.4%2022-$4.52M+1.5%2021-$4.59M-5.9%2020-$4.33M-50.0%2019-$2.89M-213.8%2018$2.54M+22.9%2017$2.06M-40.1%2016$3.44M+116.1%2015$1.59M+396.6%2014$321.0K+107.6%2013-$4.22M-140.2%2012-$1.76M-148.5%2011$3.62M-32.8%2010$5.39M+337.4%2009-$2.27M-624.2%2008$433.0K+104.2%2007$212.0K-95.5%2006$4.70M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share